Key result
Complete CTSD knockout reduced markers of severity in both early (1 h) and late (8 h) phases of experimental pancreatitis, whereas pancreas-specific knockout only reduced severity at 1 h.
Cathepsin D regulates disease severity in experimental acute pancreatitis predominantly through inflammatory cells in the later phase of the disease.
Answers are grounded in this paper and cite their sources.
CTSD targeting may modulate pancreatitis inflammation; leaves open translation from mouse knockouts to clinical therapies.
Acute pancreatitis is a complex disorder involving both premature intracellular protease activation and inflammatory cell invasion. An initiating event is the intracellular activation of trypsinogen by cathepsin B (CTSB), which can be induced directly via G protein–coupled receptors on acinar cells or through inflammatory cells. Here, we studied CTSB regulation by another lysosomal hydrolase, cathepsin D (CTSD), using mice with a complete (CTSD −/− ) or pancreas-specific conditional CTSD knockout (KO) (CTSD f/f /p48 Cre/+ ). We induced acute pancreatitis by repeated caerulein injections and isolated acinar and bone marrow cells for ex vivo studies. Supramaximal caerulein stimulation induced subcellular redistribution of CTSD from the lysosomal to the zymogen-containing subcellular compartment of acinar cells and activation of CTSD, CTSB, and trypsinogen. Of note, the CTSD KO greatly reduced CTSB and trypsinogen activation in acinar cells, and CTSD directly activated CTSB but not trypsinogen in vitro . During pancreatitis in pancreas-specific CTSD f/f /p48 Cre/+ animals, markers of severity were reduced only at 1 h, whereas in the complete KO, this effect also included the late disease phase (8 h), indicating an important effect of extra-acinar CTSD on course of the disease. CTSD −/− leukocytes exhibited reduced cytokine release after lipopolysaccharide (LPS) stimulation, and CTSD KO also reduced caspase-3 activation and apoptosis in acinar cells stimulated with the intestinal hormone cholecystokinin. In summary, CTSD is expressed in pancreatic acinar and inflammatory cells, undergoes subcellular redistribution and activation during experimental pancreatitis, and regulates disease severity by potently activating CTSB. Its impact is only minimal and transient in the early, acinar cell–dependent phase of pancreatitis and much greater in the later, inflammatory cell–dependent phase of the disease.
No takes yet. Share an insight, caveat, or question.
Aghdassi et al. (2017) studied Acute pancreatitis. Complete or pancreas-specific conditional CTSD knockout vs. Control mice was evaluated on Disease severity markers and CTSB/trypsinogen activation. Complete CTSD knockout reduced markers of severity in both early (1 h) and late (8 h) phases of experimental pancreatitis, whereas pancreas-specific knockout only reduced severity at 1 h.
Synapse has enriched 10 related papers. Consider them for comparative context: